Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brintellix in bipolar depression
NCT03598868Phase 2Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Aug 2018
- Primary completion
- Sep 2021
- Countries
- 1
01
Overview
A Phase 2 trial of vortioxetine in bipolar disorder (BD), sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
vortioxetine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT03598868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03598868.